Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003

Completed · Phase 2 · Has a placebo group

Conditions studied: Uterine Fibroids

In brief

ZPU-003 EXT is a 2-year extension study of ZPU-003 (NCT00882258) to determine the continued safety and efficacy of Proellex in women who have previously completed the double-blind portion of the study.

Key facts

Study ID

NCT00958334

Run by

Repros Therapeutics Inc.

People needed

65

Starts

2006-09-07

Expected to finish

2008-10-15

Last updated by the study team

2019-06-18

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Completed the ZPU 003 study and met the inclusion/exclusion criteria of that study.

You may not qualify if…

• Low or high grade cervical dysplasia, as determined by Papanicolaou (PAP) smear.
• Pregnant or breastfeeding.

Where it is running

• Women's Health Research — Phoenix, Arizona, United States
• Arizona Wellness Centre for Women — Phoenix, Arizona, United States
• Medical Centre for Clinical Research — San Diego, California, United States
• Women's Health Care, Inc. — San Diego, California, United States
• Downtown Women's Health Care — Denver, Colorado, United States
• Insignia Clinical Research (Tampa Bay Women's Center) — Tampa, Florida, United States
• Affiliated Clinical Research, Inc. — Las Vegas, Nevada, United States
• SC Clinical Research Center — Columbia, South Carolina, United States
• Advances in Health Inc. — Houston, Texas, United States
• Obstetrical & Gynecolgical Associates, PA (OGA) — Houston, Texas, United States
• Women's Clinical Research Centre — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.